Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy

Conditions: Bladder Urothelial Carcinoma; Muscle Invasive Bladder Carcinoma; Stage II Bladder Cancer AJCC v8; Stage IIIA Bladder Cancer AJCC v8 Interventions: Procedure: Biospecimen Collection; Procedure: Computed Tomography; Biological: Durvalumab; Drug: Futibatinib; Procedure: Magnetic Resonance Imaging; Procedure: Radical Cystectomy Sponsors: Yuanquan Yang; Gateway for Cancer Research Not yet recruiting

https://clinicaltrials.gov/study/NCT06263153

Source: ClinicalTrials.gov - February 16, 2024 Category: Research Source Type: clinical trials